MedWatch

Orifarm says goodbye to generics CEO following new focus on generic medicine

Orifarm has presented a new strategy, which is focused on Orifarm producing its own generic medicine, therefore the company has said goodbye to the CEO of the company's generics business. "We have simply removed a layer of management," says Deputy CEO.

In future, Erik Sandberg, Deputy CEO of Orifarm, will be in charge of the company's generics business. | Foto: Orifarm

The Danish company Orifarm has said goodbye to Ulrik Rasmussen, who was CEO of the company's generic business.

Ulrik Rasmussen's departure coincides with Orifarm presenting a new strategy, in which the company will increasingly manufacture its own generic medicine.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier